1Haverstock BD. Hypertrophic scar and keloids[J]. Clin Podiatr Med Surg, 2001, 18:147.
2Lawrence WT. In search of the optimal treatment of keloids: report of a series and a review of the literature[J]. Ann Plast Surg, 1991, 43: 164.
3Shons AR, Press BH. The treatment of earlobe keloids by surgical excision and postoperative triamcinolone injection[J]. Ann Plast Surg, 1983,10(6): 480.
4Golladay ES. Treatment of keloids by single intraoperative perilesional injection of repository steroid[J]. South Med J,1988,81(6):736.
5Chowdri NA, Masarat M, Mattoo A. Keloid and hypertrophic scars: results with intraoperative and serial postoperative corticosteroid injection therapy[J]. Aust N Z J Surg,1999, 9(9):655.
6WANG R,GHAHARY A,SHEN Q,et al.Hypertrophic scar tissues and fibroblasts produce more transforming growth factor-beta1 mRNA and protein than normal skin and cells[J].Wound Repair Regen,2000,8:128-137.
7CHODON T,SUGIHARA T,IGAWA H H,et al.Keloidderived fibroblasts are refractory to Fas-mediated apoptosis and neutralization of autocrine transforming growth factor-beta1 can abrogate this resistance[J].Am J Pathol,2000,157:1661-1669.
8BULLITT E,LEE C L,LIGHT A R,et al.The effect of stimulus duration on noxious-stimulus induced c-fos expression in the rodent spinal cord[J].Brain Res,1992,580:172-181.
9HUNT S P,PINI A,EVANS G.Induction of c-fos like protein in spinal cord neurons following sensory stimulation[J].Nature,1987,328:632.
10NARA T.Histamine and 5-hydroxytryptamine in human scar tissue[J].Ann Plast Surg,1985,14:244-247.
